Operational models of pharmacological agonism - PubMed (original) (raw)
Comparative Study
. 1983 Dec 22;220(1219):141-62.
doi: 10.1098/rspb.1983.0093.
- PMID: 6141562
- DOI: 10.1098/rspb.1983.0093
Comparative Study
Operational models of pharmacological agonism
J W Black et al. Proc R Soc Lond B Biol Sci. 1983.
Abstract
The traditional receptor-stimulus model of agonism began with a description of drug action based on the law of mass action and has developed by a series of modifications, each accounting for new experimental evidence. By contrast, in this paper an approach to modelling agonism is taken that begins with the observation that experimental agonist-concentration effect, E/[A], curves are commonly hyperbolic and develops using the deduction that the relation between occupancy and effect must be hyperbolic if the law of mass action applies at the agonist-receptor level. The result is a general model that explicitly describes agonism by three parameters: an agonist-receptor dissociation constant, KA; the total receptor concentration, [R0]; and a parameter, KE, defining the transduction of agonist-receptor complex, AR, into pharmacological effect. The ratio, [R0]/KE, described here as the 'transducer ratio', tau, is a logical definition for the efficacy of an agonist in a system. The model may be extended to account for non-hyperbolic E/[A] curves with no loss of meaning. Analysis shows that an explicit formulation of the traditional receptor-stimulus model is one particular form of the general model but that it is not the simplest. An alternative model is proposed, representing the cognitive and transducer functions of a receptor, that describes agonist action with one fewer parameter than the traditional model. In addition, this model provides a chemical definition of intrinsic efficacy making this parameter experimentally accessible in principle. The alternative models are compared and contrasted with regard to their practical and conceptual utilities in experimental pharmacology.
Similar articles
- An operational model of pharmacological agonism: the effect of E/[A] curve shape on agonist dissociation constant estimation.
Black JW, Leff P, Shankley NP, Wood J. Black JW, et al. Br J Pharmacol. 1985 Feb;84(2):561-71. doi: 10.1111/j.1476-5381.1985.tb12941.x. Br J Pharmacol. 1985. PMID: 3978322 Free PMC article. - Potential errors in agonist dissociation constant estimation caused by desensitization.
Leff P. Leff P. J Theor Biol. 1986 Jul 21;121(2):221-32. doi: 10.1016/s0022-5193(86)80095-9. J Theor Biol. 1986. PMID: 3795994 - Quantifying biological activity in chemical terms: a pharmacology primer to describe drug effect.
Kenakin T. Kenakin T. ACS Chem Biol. 2009 Apr 17;4(4):249-60. doi: 10.1021/cb800299s. Epub 2009 Feb 4. ACS Chem Biol. 2009. PMID: 19193052 - Analysis of drug-receptor interactions in vivo: a new approach in pharmacokinetic-pharmacodynamic modelling.
Van der Graaf PH, Danhof M. Van der Graaf PH, et al. Int J Clin Pharmacol Ther. 1997 Oct;35(10):442-6. Int J Clin Pharmacol Ther. 1997. PMID: 9352393 Review. - Partial agonism: mechanisms based on ligand-receptor interactions and on stimulus-response coupling.
Pliska V. Pliska V. J Recept Signal Transduct Res. 1999 Jan-Jul;19(1-4):597-629. doi: 10.3109/10799899909036675. J Recept Signal Transduct Res. 1999. PMID: 10071788 Review.
Cited by
- Stimulus bias provides evidence for conformational constraints in the structure of a G protein-coupled receptor.
Gregory KJ, Sexton PM, Tobin AB, Christopoulos A. Gregory KJ, et al. J Biol Chem. 2012 Oct 26;287(44):37066-77. doi: 10.1074/jbc.M112.408534. Epub 2012 Sep 10. J Biol Chem. 2012. PMID: 22965232 Free PMC article. - Efficacy and ligand bias at the μ-opioid receptor.
Kelly E. Kelly E. Br J Pharmacol. 2013 Aug;169(7):1430-46. doi: 10.1111/bph.12222. Br J Pharmacol. 2013. PMID: 23646826 Free PMC article. Review. - A Tutorial on Pharmacodynamic Scripting Facility in Simcyp.
Abduljalil K, Edwards D, Barnett A, Rose RH, Cain T, Jamei M. Abduljalil K, et al. CPT Pharmacometrics Syst Pharmacol. 2016 Sep;5(9):455-65. doi: 10.1002/psp4.12102. Epub 2016 Aug 29. CPT Pharmacometrics Syst Pharmacol. 2016. PMID: 27393710 Free PMC article. No abstract available. - Modelling of drug-induced QT-interval prolongation: estimation approaches and translational opportunities.
Marostica E, Van Ammel K, Teisman A, Boussery K, Van Bocxlaer J, De Ridder F, Gallacher D, Vermeulen A. Marostica E, et al. J Pharmacokinet Pharmacodyn. 2015 Dec;42(6):659-79. doi: 10.1007/s10928-015-9434-0. Epub 2015 Aug 11. J Pharmacokinet Pharmacodyn. 2015. PMID: 26259721 - Clinical pharmacokinetics and pharmacodynamics of erythropoiesis-stimulating agents.
Doshi S, Krzyzanski W, Yue S, Elliott S, Chow A, Pérez-Ruixo JJ. Doshi S, et al. Clin Pharmacokinet. 2013 Dec;52(12):1063-83. doi: 10.1007/s40262-013-0098-x. Clin Pharmacokinet. 2013. PMID: 23912564 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials